Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Why Express, Ambit Biosciences, and Thompson Creek Metals Tumbled Today

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing thesis.

Investors suffered through a fourth day of losses for the broad market, as both the Dow and S&P didn't manage to avoid modest declines despite having bounced back from much larger pullbacks earlier in the session. Yet with the Dow and S&P 500 falling less than 0.2% and the Nasdaq actually rising slightly on the day, the huge declines for Express (NYSE: EXPR  ) , Ambit Biosciences (UNKNOWN: AMBI.DL  ) , and Thompson Creek Metals (NASDAQOTH: TCPTF  ) stood out among the market's losing stocks.

Express dropped by 23% after giving negative guidance in its quarterly earnings report. Even though the retailer posted reasonable gains in sales and earnings for the third quarter, Express reined in its full-year earnings expectations, cutting its expected range by $0.06 to $0.09 per share. The retailer's comments only emphasize the extent to which promotional discounting has become more prevalent than ever, pointing to the likelihood that results for the holiday quarter throughout the industry won't manage to achieve hoped-for levels.

Ambit plunged 33% following bad news concerning its acute myeloid leukemia drug prospect quizartinib. The company announced that the FDA chose not to allow it to file for approval based solely on its trial data from phase 2 and 2b studies, instead requiring it to run a more costly and time-consuming phase 3 trial before considering a new drug application. Even though the company has substantial cash reserves to sustain it as it runs the study, investors nevertheless weren't happy with the delay.

Thompson Creek posted a nearly 10% decline, falling to a new low as analysts at TD Securities kept their negative rating on the mining company and again called for the stock to drop substantially from current levels. With the company seeing substantial amounts of debt coming due in the next four to six years, Thompson Creek needs to see prices of molybdenum return to higher levels in order to help support its debt repayment. Moreover, with its Mt. Milligan exploration project not yet having proven itself -- especially with gold and copper prices depressed -- Thompson Creek could have trouble making enough money to avoid hugely dilutive measures in the future.

Get the right stocks on your side
Don't settle for weak stocks in your portfolio. Your best investment strategy is to buy shares in solid businesses and keep them for the long term. In the special free report, "3 Stocks That Will Help You Retire Rich," The Motley Fool shares investment ideas and strategies that could help you build wealth for years to come. Click here to grab your free copy today.

Read/Post Comments (4) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On December 05, 2013, at 12:48 AM, techpatriot wrote:

    Email response from TC:

    Over the past several weeks, we have been meeting with sell-side analysts and institutional holders to introduce our new CEO, review our Q3 financial results and provide an update on the Mt. Milligan ramp-up. Our message has been positive and consistent with everyone whom we've met. It is also consistent with what was stated on our conference call:

    1. The Mt. Milligan ramp-up continues to go well.

    2. We believe we will have sufficient cash to get us through the ramp-up period.

    3. We do not believe we have liquidity issues.

    4. None of our outstanding notes mature until 2017 at the earliest, which gives us several years of what we expect to be strong performance at Mt. Milligan to generate significant cash.

    5. Once Mt. Milligan is fully operational and generating cash, we will review our debt structure and consider options available to us at that time to possibly refinance, repurchase, etc. our debt.

    6. We’ve begun shipping concentrate from MTM, and expect our next shipment in January 2014.

    7. We expect to reach commercial production on Q1 2014.

    We met with TD Securities and communicated the message above. Unfortuntely, the analysts run their own models, make their own assumptions, and write what they see fit, even after they meet with us. We cannot control what they write. We will issue 2014 production and cost guidance once 2014 budgets have been approved.

    Please do not hesitate to contact me should you have additional questions or concerns. I am traveling, but will be back in the office on Friday.

    Pam Solly

    Director, Investor Relations

    303 762 3526 Less

  • Report this Comment On December 05, 2013, at 12:52 AM, techpatriot wrote:

    Also, I might also point out that the TD Securities "report" assumes all the worst case scenarios for all six forecast parameters including metals pricing, throughput, grade, recovery percentage, operating costs and capex, as well as disregarding all moly production.

    The odds on all six of those items coming in at the worst case scenario for 2014 have to be on the order of extremely improbable and unlikely.

  • Report this Comment On December 05, 2013, at 7:13 AM, techpatriot wrote:

    Also, according to the TD Securities on TC under Disclosures on page 5, there appears to be what I would call something quite interesting....

    Disclosures on TC Report:

    5. A long position in the securities of the subject company is held by the research analyst, by a member of the research analyst’s household, or in an account over which the research analyst has discretion or control.

    9. TD Securities Inc. and/or an affiliated company is a market maker, or is associated with the specialist that makes a market, in the securities of the subject company

  • Report this Comment On December 05, 2013, at 5:30 PM, hank321 wrote:

    Could the TD folks be deliberately bad-mouthing the firm, order for friends to build a larger position at a bargain price? The SEC should inquire.

    LINE appears to have been victimized by this kind of a strategy in the past 4 months.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2752930, ~/Articles/ArticleHandler.aspx, 9/30/2016 8:05:23 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,308.15 164.70 0.91%
S&P 500 2,168.27 17.14 0.80%
NASD 5,312.00 42.85 0.81%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/31/1969 7:00 PM
AMBI.DL $0.00 Down +0.00 +0.00%
EXPR $11.79 Up +0.14 +1.20%
Express CAPS Rating: ****
TCPTF $0.52 Down -0.01 -1.19%
Thompson Creek Met… CAPS Rating: ***